Viewing Study NCT03452332


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:37 PM
Study NCT ID: NCT03452332
Status: COMPLETED
Last Update Posted: 2023-09-13
First Post: 2018-02-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-07-18
Start Date Type: ACTUAL
Primary Completion Date: 2023-08-11
Primary Completion Date Type: ACTUAL
Completion Date: 2023-08-11
Completion Date Type: ACTUAL
First Submit Date: 2018-02-26
First Submit QC Date: None
Study First Post Date: 2018-03-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-11
Last Update Post Date: 2023-09-13
Last Update Post Date Type: ACTUAL